1910

1910 is a Y Combinator-backed company that multimodal AI Platform for Modality Agnostic Drug Discovery™. Based in Boston, USA, the company participated in the Winter 2019 batch of Y Combinator.

We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.

1910 was part of Y Combinator's Winter 2019 cohort, has a team of approximately 20 employees, and is actively operating.